January 04, 2012
Aveo and Astellas Pharma are looking at filings for their kidney cancer treatment tivozanib later this year, after unveiling late-stage data showing a favourable survival profile over Bayer/Onyx's Nexavar.
September 26, 2011
Roche has been boosted by promising mid-stage data on T-DM1, which combines its blockbuster Herceptin with partner ImmunoGen's chemotherapy drug DM1
February 10, 2011
A late-stage study of Swiss drugmaker Roche's Avastin indicates that the drug is able to extend the time patients with ovarian cancer live without their disease worsening.
January 19, 2011
Shares in Ariad rocketed more than 30% yesterday on news that ridaforolimus - which is being developed in partnership with Merck & Co - hit its goals in a late-stage trial involving patients with sarcoma.
PharmaTimes 2013 Copyright | RSS Feed Subscriptions Website by DCSL Software